CJ Bioscience
Develops microbiome therapeutics for oncology & IBD using an AI drug discovery platform.
311690 | KO
Overview
Corporate Details
- ISIN(s):
- KR7311690002
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 중구 세종대로 14 그랜드센트럴타워 B동 7층, 중구
- Website:
- https://www.cjbioscience.com/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
CJ Bioscience, Inc. is a biopharmaceutical company focused on developing next-generation, microbiome-based therapeutics. Leveraging its proprietary AI-powered drug discovery platform, Ez-Mx®, the company analyzes the relationship between human microbiomes and disease to address unmet medical needs. Its therapeutic programs are concentrated on oncology and inflammatory bowel disease (IBD), with a pipeline of live biotherapeutic products. CJ Bioscience aims to create innovative treatments, such as orally administered drugs, designed to offer improved safety and convenience compared to existing therapies.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-28 00:00 |
Regulatory News Service
대규모기업집단현황공시[분기별공시(개별회사용)]
|
Korean | 5.9 KB | ||
| 2025-08-14 00:00 |
Regulatory News Service
지급수단별ㆍ지급기간별지급금액및분쟁조정기구에관한사항
|
Korean | 11.0 KB | ||
| 2025-08-14 00:00 |
Post-Annual General Meeting Information
임시주주총회결과
|
Korean | 7.3 KB | ||
| 2025-08-14 00:00 |
Board/Management Information
대표이사변경
|
Korean | 10.7 KB | ||
| 2025-08-14 00:00 |
Interim Report
반기보고서 (2025.06)
|
Korean | 1.4 MB | ||
| 2025-07-30 00:00 |
Pre-Annual General Meeting Information
주주총회소집공고
|
Korean | 46.5 KB | ||
| 2025-07-08 00:00 |
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
|
Korean | 4.3 KB | ||
| 2025-07-08 00:00 |
Pre-Annual General Meeting Information
주주총회소집결의
|
Korean | 9.0 KB | ||
| 2025-06-02 00:00 |
Major Shareholding Notification
대규모기업집단현황공시[연1회공시및1/4분기용(개별회사)]
|
Korean | 81.9 KB | ||
| 2025-05-15 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 1.1 MB | ||
| 2025-03-26 00:00 |
Post-Annual General Meeting Information
정기주주총회결과
|
Korean | 17.4 KB | ||
| 2025-03-17 00:00 |
Audit Report / Information
감사보고서제출
|
Korean | 26.0 KB | ||
| 2025-03-17 00:00 |
Audit Report / Information
사업보고서 (2024.12)
|
Korean | 376.8 KB | ||
| 2025-03-05 00:00 |
Pre-Annual General Meeting Information
주주총회소집공고
|
Korean | 166.0 KB | ||
| 2025-03-04 00:00 |
Pre-Annual General Meeting Information
주주총회소집결의
|
Korean | 7.4 KB |
Automate Your Workflow. Get a real-time feed of all CJ Bioscience filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for CJ Bioscience
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for CJ Bioscience via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
%20LTD/other/Cuprina_Holdings_Cayman_LTD-logo.png){kind=logo}
